India to Myanmar: Furosemide Export Trade Route
India has recorded 12 verified shipments of Furosemide exported to Myanmar, representing a combined trade value of $668.9K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $55.7K USD. The leading Indian exporter is LINCOLN PHARMACEUTICALS LTD, which accounts for 94% of total export value with 2 shipments worth $630.6K USD. On the buying side, UNIVERSAL CO. LTD. is the largest importer in Myanmar with $630.6K USD in purchases. The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, MICRON PHARMACEUTICALS, LINCOLN PHARMACEUTICALS LTD — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Furosemide corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $668.9K USD. The route is dominated by LINCOLN PHARMACEUTICALS LTD, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's furosemide manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $55.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 24.1%, placing it at rank #11 among India's top furosemide export destinations globally.
On the import side, key buyers of Indian furosemide in Myanmar include UNIVERSAL CO. LTD., READY MEDICINE CO LTD, LIBERTY GROUP TRADING LTD, and 6 others. UNIVERSAL CO. LTD. is the single largest importer with 2 shipments valued at $630.6K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#11
- Annual growth+24.1%
- Demand growth+22.2%
- Regulatory ease69/100
Top 10 Indian Furosemide Exporters to Myanmar
Showing top 10 of 7 Indian suppliers exporting Furosemide to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD Avg $315.3K per shipment | 2 | $630.6K | 94.3% |
| 2 | MICRON PHARMACEUTICALS Avg $8.1K per shipment | 2 | $16.2K | 2.4% |
| 3 | LINCOLN PHARMACEUTICALS LTD Avg $3.3K per shipment | 2 | $6.7K | 1.0% |
| 4 | BOHRA LIFESCIENCE PRIVATE LIMITED Avg $2.8K per shipment | 2 | $5.6K | 0.8% |
| 5 | FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED Avg $2.8K per shipment | 2 | $5.5K | 0.8% |
| 6 | MEDOPHARM Avg $2.3K per shipment | 1 | $2.3K | 0.3% |
| 7 | KAUSIKH THERAPEUTICS PRIVATE LIMITED Avg $2.1K per shipment | 1 | $2.1K | 0.3% |
This table shows the top 10 of 7 Indian companies exporting furosemide to Myanmar, ranked by total trade value. The listed exporters are: LINCOLN PHARMACEUTICALS LTD, MICRON PHARMACEUTICALS, LINCOLN PHARMACEUTICALS LTD , BOHRA LIFESCIENCE PRIVATE LIMITED , FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED, MEDOPHARM , KAUSIKH THERAPEUTICS PRIVATE LIMITED . LINCOLN PHARMACEUTICALS LTD is the dominant supplier with 2 shipments worth $630.6K USD, giving it a 94% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Furosemide Importers in Myanmar
Showing top 10 of 9 known buyers in Myanmar receiving Furosemide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian furosemide in Myanmar include UNIVERSAL CO. LTD., READY MEDICINE CO LTD, LIBERTY GROUP TRADING LTD, , To the order,, UNIVERSAL CO. LTD. , among 9 total buyers. The largest importer is UNIVERSAL CO. LTD., accounting for $630.6K USD across 2 shipments — representing 94% of all furosemide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNIVERSAL CO. LTD. | 2 | $630.6K | 94.3% |
| 2 | READY MEDICINE CO LTD | 1 | $13.9K | 2.1% |
| 3 | LIBERTY GROUP TRADING LTD, | 2 | $5.6K | 0.8% |
| 4 | To the order, | 2 | $5.5K | 0.8% |
| 5 | UNIVERSAL CO. LTD. | 1 | $3.8K | 0.6% |
| 6 | WIN HTUN GARMENT TRADING LTD | 1 | $2.9K | 0.4% |
| 7 | READY MEDICINE CO. LTD. | 1 | $2.4K | 0.4% |
| 8 | M/S. ACRO COMPANY LTD | 1 | $2.3K | 0.3% |
| 9 | AMETHYST CO LTD | 1 | $2.1K | 0.3% |
Top 10 Furosemide Formulations Imported by Myanmar
Showing top 10 of 9 product formulations shipped on the India to Myanmar Furosemide route, ranked by trade value
Myanmar imports a wide range of furosemide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Furosemide Tablets BP 40 mg (FUROSE) (49 — accounts for $630.6K USD across 2 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Furosemide Tablets BP 40 mg (FUROSE) (49 | 2 | $630.6K | 94.3% |
| 2 | FUROMIC 40 FUROSEMIDE TABLETS 40MG | 1 | $13.9K | 2.1% |
| 3 | PHARMACEUTICAL PRODUCTS Furosemide Ta | 2 | $5.6K | 0.8% |
| 4 | PHARMACEUTICAL FINISHED FORMULATION FLAGAMIDE, Furosemide Injection BP, 10mg/ml, 10 x 2ml, ampoule, ( E ), Myanmar. | 2 | $5.5K | 0.8% |
| 5 | Furosemide Tablets BP 40 mg (FUROSE) (49 | 1 | $3.8K | 0.6% |
| 6 | FUROSEMIDE TABLETS BP 40 MG (FUROSE) (38 | 1 | $2.9K | 0.4% |
| 7 | FUROMIC-40 FUROSEMIDE TABLETS 40MG | 1 | $2.4K | 0.4% |
| 8 | UROMID TABLET (FUROSEMIDE BP 40MG (7000 | 1 | $2.3K | 0.3% |
| 9 | FUROSEMIDE 40MG TABS(8X400X10X10+ 1X100X | 1 | $2.1K | 0.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 2 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's furosemide exports to Myanmar are driven primarily by a handful of large-scale manufacturers. LINCOLN PHARMACEUTICALS LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, MICRON PHARMACEUTICALS, LINCOLN PHARMACEUTICALS LTD — together account for 98% of total trade value on this route. The average shipment value of $55.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as furomic 40 furosemide tablets 40mg and pharmaceutical products furosemide ta , suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UNIVERSAL CO. LTD. is the largest importer with 2 shipments worth $630.6K USD — representing 94% of all furosemide imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $668.9K
- Avg. Shipment
- $55.7K
- Suppliers
- 7
- Buyers
- 9
- Transit (Sea)
- ~18 days
- Annual Growth
- +24.1%
Related Analysis
Other Furosemide Routes
Unlock the Full India to Myanmar Furosemide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 12 shipments on this route.
Frequently Asked Questions — India to Myanmar Furosemide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Furosemide to Myanmar?
The leading Indian exporters of Furosemide to Myanmar are LINCOLN PHARMACEUTICALS LTD, MICRON PHARMACEUTICALS, LINCOLN PHARMACEUTICALS LTD . LINCOLN PHARMACEUTICALS LTD holds the largest market share at approximately 94% of total trade value on this route.
Q What is the total value of Furosemide exports from India to Myanmar?
India exports Furosemide to Myanmar worth approximately $668.9K USD across 12 recorded shipments. The average value per shipment is $55.7K USD.
Q Which ports does India use to ship Furosemide to Myanmar?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 2 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Myanmar for Furosemide?
The average transit time for Furosemide shipments from India to Myanmar is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Myanmar Furosemide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.1% with demand growth tracking at 22.2%. The route is ranked #11 among India's top Furosemide export destinations globally.
Q How many suppliers are active on the India to Myanmar Furosemide route?
There are currently 7 active Indian suppliers exporting Furosemide to Myanmar. The market is moderately concentrated with LINCOLN PHARMACEUTICALS LTD accounting for 94% of total shipment value.
Q Who are the main importers of Furosemide from India in Myanmar?
The leading importers of Indian Furosemide in Myanmar include UNIVERSAL CO. LTD., READY MEDICINE CO LTD, LIBERTY GROUP TRADING LTD, , To the order,, UNIVERSAL CO. LTD. . UNIVERSAL CO. LTD. is the largest buyer with 2 shipments worth $630.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Furosemide.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 9 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 12 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists